Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$32.6B
452M shares
52-week range
$58.75 – $89.77
48% from low
Sector
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Exchange
NASDAQ
CS
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
www.gehealthcare.comNo one on the platform currently holds GEHC.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 254,100 | $18.1M |
| Bridgewater Associatesas of 2026-03-31 | 71,811 | $5.1M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-24 | $0.0350 | 2026-08-14 |
| 2026-04-02 | $0.0350 | 2026-05-15 |
| 2026-01-09 | $0.0350 | 2026-02-13 |
| 2025-10-24 | $0.0350 | 2025-11-14 |
| 2025-07-25 | $0.0350 | 2025-08-15 |
| 2025-04-25 | $0.0350 | 2025-05-15 |
| 2025-01-14 | $0.0350 | 2025-02-14 |
| 2024-10-18 | $0.0300 | 2024-11-15 |
| 2024-07-19 | $0.0300 | 2024-08-15 |
| 2024-04-18 | $0.0300 | 2024-05-15 |
No one on the platform has traded GEHC yet.
| 2024-01-12 | $0.0300 | 2024-02-15 |
| 2023-10-19 | $0.0300 | 2023-11-15 |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $21.7B | +5.8% | $4.92 | $4.87–$4.99 | 15.0× | 12 |
| 2027 | $22.7B | +4.6% | $5.43 | $5.16–$5.53 | 13.6× | 12 |
| 2028 | $23.8B | +4.8% | $6.04 | $5.41–$6.40 | 12.2× | 8 |
| 2029 | $25.1B | +5.3% | $6.67 | $6.57–$6.76 | 11.1× | 5 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-29 | $1.04 | $1.13 | +8.7% |
| 2026-04-29 | $1.04 | $0.99 | -4.8% |
| 2026-02-04 | $1.40 | $1.44 | +2.9% |
| 2025-10-29 | $1.05 | $1.07 | +1.9% |
| 2025-07-30 | $0.92 | $1.06 | +15.5% |
| 2025-04-30 | $0.91 | $1.01 | +10.5% |
| 2025-02-13 | $1.26 | $1.45 | +15.1% |
| 2024-10-30 | $1.05 |
| $1.14 |
| +8.6% |
| $46.2B |
| — |
| INSMInsmed Incorporated | $126.33 | -4.50% | $27.4B | — |
| IQVIQVIA Holdings Inc. | $241.52 | -0.08% | $39.8B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BSX Insiders loading. They did the same at $GEHC and $AVTR which both recently started a new uptrend.
View on StockTwits ↗$gehc https://finance.yahoo.com/healthcare/articles/ge-healthcare-technologies-gehc-stock-011218947.html
View on StockTwits ↗$gehc https://finance.yahoo.com/markets/stocks/articles/ge-healthcare-technologies-gehc-just-133002443.html
View on StockTwits ↗$GEHC Argus Research Adjusts GE Healthcare Technologies PT to $85 From $80 MT Newswires August 05, 2026 11:30 AM EDT, 08/05/2026 (MT Newswires) -- GE Healthcare Technologies (GEHC) has an average rating of overweight and mean price target of $81.47, according to analysts polled by FactSet
View on StockTwits ↗$WTW $GEHC $TPR $EL $KHC Willis Towers Watson leads insurance consulting, GE HealthCare benefits from medical imaging demand, Tapestry strengthens luxury brands, Estée Lauder focuses on premium beauty, and Kraft Heinz generates dependable consumer cash flow.
View on StockTwits ↗$gehc https://finance.yahoo.com/healthcare/articles/ge-healthcare-expands-logiq-e-130000104.html
View on StockTwits ↗Q2 Earnings Winners So Far The biggest earnings reactions are showing one clear theme: Strong execution is still being rewarded. Healthcare & Medtech $BFLY +15.07% $CDNA +14.72% $GEHC +12.15% $ABT +10.71% $TMO +8.71% The takeaway: The market is rewarding companies with: • Real revenue growth • Strong margins • Clear demand trends • Positive guidance AI remains a major driver, but opportunities are expanding into cloud, infrastructure, industrials, and specialized technology. The next winners may come from the companies quietly building the future. Follow me and visit my profile for earnings breakdowns, AI infrastructure research, and high-conviction growth stock ideas before Wall Street fully prices them in.
View on StockTwits ↗$GEHC $DJI $NDAQ I hate BS articles like this. The CFO transition at GE Healthcare will be seamless. Newcomb is the new CFO, he is a long-time company employee, served as general controller for GE’s healthcare business beginning in February 2016, according to the filing with the Securities and Exchange Commission. He was named in his current role as controller and CAO at GE Healthcare in 2023, in association with its spinoff from GE, according to the filing. Over a multi-decade tenure, his past roles have included key financial leadership positions, including CFO roles at GE Capital Equipment Finance and GE Capital Healthcare Financial Services. Before joining GE in 1996, he served as a senior tax manager at Arthur Andersen. Really what is hurting all Healthcare profits is the insane rise in memory prices. That is what is holding back the sector. The BS memory price gouging going on. Now is actually the time to get in and wait and hold.
View on StockTwits ↗$GEHC Comparison Ratio Update for GE Healthcare Technology Investment Alert Comparison Ratio Update for GE Healthcare Technologies Inc GEHC's ROE is among the highest in the Health Care Equipment industry. Moreover, with a capital structure and revenue growth that are appropriate for the industry, management seems to be effective at utilizing its available resources.
View on StockTwits ↗$GEHC GE HealthCare Technologies Inc. (NASDAQ: GEHC) expects stronger revenue and earnings, but its CFO’s sudden departure could complicate the GEHC stock outlook. https://globalmarketbulletin.com/is-ge-healthcare-gehc-a-smart-long-term-investment/
View on StockTwits ↗$AVTR $GEHC Come on you turds! Neither of you going to hold the earnings gap??
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.